{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:04:28Z","timestamp":1771869868494,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euros.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:55:46Z","timestamp":1769111746000},"page":"58-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reply to Asim Armagan Aydin, Erkan Kayikcioglu, and Ramazan Oguz Yuceer\u2019s Letter to the Editor re: Muhammet Demirbilek, G\u00f6ktu\u011f Kalender, Said B\u0131y\u0131koglu, et al. External Validation of Nomograms for Predicting Pelvic Lymph Node Metastases in Patients with Prostate Cancer and the Added Value of the Prostate-specific Membrane Antigen Positron Emission Tomography\u2013based PRIMARY Score. Eur Urol Open Sci 2025;82:170\u20137"],"prefix":"10.1016","volume":"84","author":[{"given":"B\u00fclent","family":"\u00d6nal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet","family":"Demirbilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Kabasakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.01.002_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.euros.2025.10.020","article-title":"External validation of nomograms for predicting pelvic lymph node metastases in patients with prostate cancer and the added value of the prostate-specific membrane antigen positron emission tomography\u2013based PRIMARY score","volume":"82","author":"Demirbilek","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.01.002_b0010","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"Mottet","year":"2023"},{"key":"10.1016\/j.euros.2026.01.002_b0015","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"Cornford","year":"2025"},{"key":"10.1016\/j.euros.2026.01.002_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.01.002_b0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JU.0000000000004587","article-title":"Pelvic lymph node dissection in prostate cancer: is it really necessary? A multicentric longitudinal study assessing oncological outcomes in patients with prostate cancer undergoing pelvic lymph node dissection vs radical prostatectomy only","volume":"214","author":"Furrer","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.01.002_b0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.euo.2023.03.010","volume":"6","author":"Vis","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.01.002_b0035","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1007\/s00259-025-07241-y","article-title":"External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer","volume":"52","author":"Van Bergen","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.euros.2026.01.002_b0040","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-023-06556-y","article-title":"Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET\/CT: a potential tool for selecting patients for active surveillance","volume":"51","author":"Akcay","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.euros.2026.01.002_b0045","doi-asserted-by":"crossref","unstructured":"Karpinski MJ, Hober\u00fcck S, Fendler WP, et al. Association between the PRIMARY score at staging prostate-specific membrane antigen positron emission tomography and overall survival among patients with newly diagnosed prostate cancer: findings from the international, multicenter PROMISE registry. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2025.10.013.","DOI":"10.1016\/j.eururo.2025.10.013"},{"key":"10.1016\/j.euros.2026.01.002_b0050","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1007\/s00259-023-06332-y","article-title":"Is PSMA PET\/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial","volume":"50","author":"Holzgreve","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832600008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832600008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:05:00Z","timestamp":1771866300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616832600008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"alternative-id":["S266616832600008X"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.01.002","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to Asim Armagan Aydin, Erkan Kayikcioglu, and Ramazan Oguz Yuceer\u2019s Letter to the Editor re: Muhammet Demirbilek, G\u00f6ktu\u011f Kalender, Said B\u0131y\u0131koglu, et al. External Validation of Nomograms for Predicting Pelvic Lymph Node Metastases in Patients with Prostate Cancer and the Added Value of the Prostate-specific Membrane Antigen Positron Emission Tomography\u2013based PRIMARY Score. Eur Urol Open Sci 2025;82:170\u20137","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}